Maxona Pharmaceuticals, Inc. — Form D
Maxona Pharmaceuticals, Inc. of Malvern, PA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-05. The offering totals $10.0M, of which $5.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-05-05
- Form: D
- Accession: 0001857448-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $5.6M
- Remaining: $4.4M
- Investors: 34
- Date of first sale: 2021-04-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-398344
Issuer
- Name: Maxona Pharmaceuticals, Inc.
- CIK: 0001857448
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 101 Lindenwood Drive, Malvern, PA, 19355
- Phone: 484.681.5626
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| David Nakamura | Director | Malvern, PA |
| Shahin Fatholahi | Director | Malvern, PA |
| Shahin Fatholahi | Executive Officer | Malvern, PA |
| Richard Brand | Executive Officer | Malvern, PA |
| Behshad Sheldon | Director | Malvern, PA |
Other filings by this issuer (1)
More